Dow Chemical Company (DOW) is planning to sell more non-core assets in 2010 to pay off debt from its $16.5 billion acquisition of rival Rohm and Haas in April of this year. It is planning further debt reductions of about $12 billion. Dow stated that it plans to lighten its debt load and achieve its financial targets ahead of schedule. The Rohm and Haas acquisition is proving to be positive for Dow, which is expected to consolidate higher-margin and higher-growth specialty businesses and reduce volatility in earnings and cash flow, going forward. Dow is aiming to nearly double margins and quadruple earnings per share while reducing debt in the coming years. The company has predicted earnings of $4 to $4.50 per share in 2012 (up from last year’s $1.82) to be achieved through a mix of growth synergies as well as restructuring and cost synergies. ...

We have upgraded Dow Chemical Company (DOW) from Neutral to Outperform. Earnings of 24 cents in the third quarter of 2009 (significantly better than the Zacks Consensus Estimate of 9 cents, and the 5 cents reported in the previous quarter) were driven by cost reduction and asset sales.

The company achieved cost synergies of over $1 billion in the first nine months of 2009. The Rohm and Haas acquisition is a positive for Dow, which is expected to consolidate higher margin and higher growth specialty businesses and reduce volatility in earnings and cash flow going forward.Zacks Investment Research

Monro Muffler Brake Inc. (...

For Immediate Release

Chicago, IL – October 7, 2009 – Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.

The four highlighted picks are: Cnooc Limited (CEO), Carlisle Companies Inc. (CSL), Dow Chemical Co. (DOW) and Odyssey Healthcare, Inc. (ODSY).      Today, Zacks is promoting its ''Buy'' stock recommendations. Four daily picks are offered free at http://at.zacks.com/?id=5607

Zacks #1 Rank Stocks have nearly tripled the S&P 500 since 1988, producing an average annual return of +26%. Performance has been notable even during volatile and down times. For example, during the last bear market, 2000-2002, the market tumbled -37.6% – but Zacks #1 Rank stocks gained +43.8%.

Here is a

...

Dow Chemical Co. (...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Friday September 18, 2009

DrStockPick.com Stock Report!

**************************************************************

Cavico Corp. (NASDAQ:CAVO), a leading infrastructure development company based in Vietnam, announced today that its common stock has been approved for listing on The NASDAQ Capital Market under the ticker symbol CAVO. Trading on The NASDAQ Capital Market will commence today.

Avago Technologies Limited (Nasdaq:AVGO), a leading designer, developer and global supplier of analog semiconductor devices, today announced the early tender results for the cash tender offer by its wholly owned subsidiary, Avago Technologies Finance Pte. Ltd.

...

Dow Chemical Co. (DOW) completed the sale of its Netherlands-based crude oil refinery to Paris-based Total SA (TOT), one of the six major global oil companies, for about $800 million. The refinery is a key supplier of refined products, including diesel, to the European market. The move is in line with Dow’s strategy of divesting non-core assets. The deal received regulatory approval last month.

The Midlands, Michigan-based chemical company stated that the divestiture will increase its financial flexibility, improve cash flow and will help pay down debt. The company plans to use the proceeds from the deal to pay down debt, which was raised for the Rohm and Haas acquisition.

The Rohm and Haas acquisition increased Dow’s net debt from $8 billion to $22 billion in the first half of 2009. This resulted in a significant net cash deficit of $19 billion during the period. However, Dow Chemical has become

...

On Aug. 3, Dow Chemical Co. (DOW) reportedly agreed to sell its acrylic acid and esters plant in Clear Lake, Texas, and the North American UCAR Emulsion Systems specialty latex businesses to Arkema Inc. for $50 million. Arkema is a global chemical company and France’s leading chemicals producer, specializing in Vinyl Products, Industrial Chemicals and Performance Products.

Media reports said that Dow would use proceeds from the sale for further de-leveraging which will be accretive to the company’s shareholders. The U.S. Federal Trade Commission (FTC) should approve Arkema as the buyer of Dow’s assets. The deal is expected to close in the fourth quarter of 2009.

Earlier in July, Dow had entered an agreement with Petroliam Nasional Berhad (PETRONAS) of Malaysia, a state-owned integrated oil and gas corporation, to divest its ownership in Optimal Group of Co.s for $660 million. This transaction is likely to close by the

...

Monday February 9, 2008
Navivest

The Obama administration, which was going to announce a bank rescue plan today, decided to push back that announcement to Tuesday.

Today, the U.S. Senate will be voting on Obama’s stimulus plan, which the administration hopes will boost the economy and according to treasury spokesman Isaac Baker, the administration wants to spend the day working on making sure the stimulus plan passes the Senate.

On Friday, the stock market rallied strongly led by financials, on anticipation of the bank rescue plan announcement from the Treasury Department and we might see an extension of that as the delay might actually turn out to be positive for the stock market.

Stocks tend to climb on anticipation of news and then fall on the actual news. So we might see another financial led rally again today.

There isn’t any economic news due today that could dictate direction for the stock

…

Friday January 23, 2009
Navivest

The Federal Trade Commission today gave Dow (DOW) the green light to complete its $18.8 billion proposed acquisition of Rohm and Haas (ROH). On January 8, Dow received EU clearance to go forward with the deal.

The FTC was concerned that Dow’s proposed $18.8 billion acquisition of rival chemical manufacturer Rohm & Haas Company would be anticompetitive and would violate federal law.

As a condition of the FTC’s consent decree, Dow will have to divest certain business lines.

Under terms of the merger agreement that it signed with Rohm and Haas, Dow has to consummate the deal within two days of receiving FTC approval.

Depending on whether that was two business days or not, we should hear something by Sunday or Tuesday.

This morning, we recommended that subscribers to our Navivest Equity Trader advisory service buy Rohm and Haas shares. We also made the same recommendation on this

…